Advancing Epitope Discovery, Target Identification & Immune Monitoring!

In the past, we have covered the technical details of peptide libraries and the early stages of medicinal research including biological screening assays and biomarker discovery. Now, we will dive into the more immunological aspect. Understanding how the immune system recognizes antigens is central to modern medicinal research. Whether developing vaccines, characterizing T cell immune responses to infection, or discovering tumor-specific neo-epitopes in oncology, researchers rely on precise tools to dissect immune recognition at the molecular level. 

JPT offers the largest portfolio of peptide formats with defined sequences, controlled variants, and customizable modifications. 

1. Epitope Discovery 

Epitope discovery involves identifying the exact peptide sequences recognized by immune receptors. These epitopes dictate immune activation, tolerance, and specificity, making them essential for therapeutic target selection. 

Overlapping Peptide Libraries: 

One of the most widely used formats in immunology, overlapping libraries enable full antigen coverage with high resolution. By covering the entire protein sequence in small incremental steps, overlapping peptides may reveal the exact regions responsible for immune activation. They are ideal for: 

• Mapping CD4⁺ and CD8⁺ T-cell epitopes 
• Identifying antibody-binding regions 
• Characterizing immune responses to infectious agents 
• Screening tumor-associated or neoantigen sequences 

2. Neo-Epitope Screening in Oncology 

Cancer immunotherapy increasingly relies on identifying patient-specific neo-epitopes arising from tumor mutations. These altered peptides may form the basis for personalized vaccines or T-cell therapies. 

PepTrack Neo-Epitope Libraries 

The PepTrack layout may include point mutations, indels, frame shifts, tumor-specific alternative reading frames and WT-mutant peptide pairs for comparative screening, which in turn support: 

• T-cell activation assays 
• Antigen-presentation studies 
• High-throughput neo-antigen prioritization 
• Identification of immunogenic mutations for personalized treatment concepts 

3. Identifying Immune-Dominant Antigens 

Some antigenic regions elicit stronger immune responses than others. Characterizing these immune-dominant sites is key for vaccine development, diagnostics, and immune monitoring. 

Truncation & Alanine Scanning Libraries 

• Identify critical residues required for immune recognition 
• Refine minimal epitope sequences 
• Differentiate dominant from subdominant antigen regions 
• Characterize structure-function relationships in epitopes 

Alanine scanning in particular is essential for validating immune-dominant determinants by systematically testing residue importance within an epitope. 

Positional Scanning Peptide Libraries (PSL): 

• Define TCR cross-reactivity patterns 
• Explore immune tolerance and escape mechanisms 
• Identify optimized peptide variants for stronger immune responses 

This is especially relevant for understanding *immune escape mutations* and predicting emerging antigenic variants in viruses or tumors. 

Additional Useful Formats:

 Beyond classical epitope-mapping sets, several specialized formats support deeper immunological insights: 

• Scrambled Peptide Libraries: For specificity controls and background discrimination in immunoassays. 
• Modified Peptide Libraries: Including phosphorylation, acetylation, methylation, lipidation, and other PTMs relevant for: Autoimmunity research Neo-antigen presentation Signal transduction pathways 
• Biotinylated Peptides: For T-cell tetramers, pull-downs, MHC binding studies, and affinity characterization.